Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kowey

Showing results (351-360 of 451) with videos related to

Pageof 46
Sort By:
Journal of the American Heart Association|December 24, 2017
Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)Kevin L Thomas, Larry R Jackson, Peter Shrader, et al.
American Heart Journal|April 30, 2017
Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research ConsortiumJonathan P Piccini, Richard L Clark, Peter R Kowey, et al.
American Heart Journal|November 9, 2016
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Peter Shrader, Sunghee Kim, et al.
The American Journal of Cardiology|November 29, 2005
Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studiesAlbert A Carr, Peter R Kowey, Richard B Devereux, et al.
American Heart Journal|June 15, 2016
The Cardiac Safety Research Consortium enters its second decade: An invitation to participateJ Rick Turner, Peter R Kowey, Ignacio Rodriguez, et al.
American Heart Journal|June 20, 2018
The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research ConsortiumPeter F Aziz, Stuart Berger, Peter Kowey, et al.
Circulation. Arrhythmia and Electrophysiology|February 24, 2022
Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus RhythmHarry J G M Crijns, Arif Elvan, Nadea Al-Windy, et al.
JAMA Cardiology|January 19, 2017
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A ReviewPaul L Hess, Jeff S Healey, Christopher B Granger, et al.
American Heart Journal|September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Heart Rhythm|February 6, 2017
The burden of proof: The current state of atrial fibrillation prevention and treatment trialsRosita Zakeri, David R Van Wagoner, Hugh Calkins, et al.
Pageof 46

Showing results (351-360 of 451) with videos related to

Sort By:
Pageof 46
Journal of the American Heart Association|December 24, 2017
Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation)Kevin L Thomas, Larry R Jackson, Peter Shrader, et al.
American Heart Journal|April 30, 2017
Long-term electrocardiographic safety monitoring in clinical drug development: A report from the Cardiac Safety Research ConsortiumJonathan P Piccini, Richard L Clark, Peter R Kowey, et al.
American Heart Journal|November 9, 2016
How well does physician risk assessment predict stroke and bleeding in atrial fibrillation? Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Benjamin A Steinberg, Peter Shrader, Sunghee Kim, et al.
The American Journal of Cardiology|November 29, 2005
Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studiesAlbert A Carr, Peter R Kowey, Richard B Devereux, et al.
American Heart Journal|June 15, 2016
The Cardiac Safety Research Consortium enters its second decade: An invitation to participateJ Rick Turner, Peter R Kowey, Ignacio Rodriguez, et al.
American Heart Journal|June 20, 2018
The Second Annual Think Tank on Prevention of Sudden Cardiac Death in the Young: Developing a rational, reliable, and sustainable national health care resource. A report from the Cardiac Safety Research ConsortiumPeter F Aziz, Stuart Berger, Peter Kowey, et al.
Circulation. Arrhythmia and Electrophysiology|February 24, 2022
Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus RhythmHarry J G M Crijns, Arif Elvan, Nadea Al-Windy, et al.
JAMA Cardiology|January 19, 2017
The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A ReviewPaul L Hess, Jeff S Healey, Christopher B Granger, et al.
American Heart Journal|September 29, 2014
Reasons for warfarin discontinuation in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)Emily C O'Brien, DaJuanicia N Simon, Larry A Allen, et al.
Heart Rhythm|February 6, 2017
The burden of proof: The current state of atrial fibrillation prevention and treatment trialsRosita Zakeri, David R Van Wagoner, Hugh Calkins, et al.
Pageof 46